$ISTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ISTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ISTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ISTA PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 8.11 | 1,662 | 13,479 | 32,438 | 34.1 K to 32.4 K (-4.87 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 20,800 | 21 | 34,100 | 13.3 K to 34.1 K (+156.39 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.09 | 6,000 | 48,525 | 792,712 | 798.7 K to 792.7 K (-0.75 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.01 | 3,000 | 24,018 | 798,712 | 801.7 K to 798.7 K (-0.37 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 147 | 1,191 | 801,712 | 801.9 K to 801.7 K (-0.02 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.09 | 14,000 | 113,225 | 1,849,659 | 1.9 M to 1.8 M (-0.75 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.01 | 7,000 | 56,041 | 1,863,659 | 1.9 M to 1.9 M (-0.37 %) |
Feb 22 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 343 | 2,778 | 1,870,659 | 1.9 M to 1.9 M (-0.02 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 7.43 | 16,429 | 122,067 | 16,429 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 6.77 | 18,427 | 124,751 | 18,427 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 7.43 | 13,571 | 100,833 | 13,571 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 6.77 | 13,673 | 92,566 | 13,673 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Sell | D | 8.11 | 375 | 3,041 | 10,825 | 11.2 K to 10.8 K (-3.35 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 7,000 | 7 | 11,200 | 4.2 K to 11.2 K (+166.67 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 4,200 | 4 | 4,200 | 0 to 4.2 K |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 7.43 | 23,081 | 171,492 | 23,081 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 6.77 | 16,182 | 109,552 | 16,182 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 7.43 | 12,919 | 95,988 | 12,919 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 6.77 | 27,218 | 184,266 | 27,218 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 8.11 | 545 | 4,420 | 12,555 | 13.1 K to 12.6 K (-4.16 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 7,000 | 7 | 13,100 | 6.1 K to 13.1 K (+114.75 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 6,100 | 6 | 6,100 | 0 to 6.1 K |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 7.43 | 19,271 | 143,184 | 19,271 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 6.77 | 14,966 | 101,320 | 14,966 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 7.43 | 15,729 | 116,866 | 15,729 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 6.77 | 15,334 | 103,811 | 15,334 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Sell | D | 8.11 | 348 | 2,822 | 11,552 | 11.9 K to 11.6 K (-2.92 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Grant | A | 0.00 | 8,000 | 8 | 11,900 | 3.9 K to 11.9 K (+205.13 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Grant | A | 0.00 | 3,900 | 4 | 3,900 | 0 to 3.9 K |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 7.43 | 17,405 | 129,319 | 17,405 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 7.43 | 6,795 | 50,487 | 6,795 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 5,500 | 6 | 9,500 | 4 K to 9.5 K (+137.50 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.01 | 2,000 | 20 | 4,000 | 2 K to 4 K (+100.00 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 7.43 | 15,662 | 116,369 | 15,662 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 6.77 | 17,467 | 118,252 | 17,467 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 7.43 | 13,338 | 99,101 | 13,338 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 6.77 | 14,633 | 99,065 | 14,633 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 8.11 | 423 | 3,431 | 10,177 | 10.6 K to 10.2 K (-3.99 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Grant | A | 0.00 | 6,300 | 6 | 10,600 | 4.3 K to 10.6 K (+146.51 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Grant | A | 0.00 | 4,300 | 4 | 4,300 | 0 to 4.3 K |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 7.43 | 22,283 | 165,563 | 22,283 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 6.77 | 22,697 | 153,659 | 22,697 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 7.43 | 13,717 | 101,917 | 13,717 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 6.77 | 17,203 | 116,464 | 17,203 | |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Sell | D | 8.11 | 500 | 4,055 | 17,100 | 17.6 K to 17.1 K (-2.84 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Grant | A | 0.00 | 7,000 | 7 | 17,600 | 10.6 K to 17.6 K (+66.04 %) |
Feb 21 2007 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Grant | A | 0.00 | 5,600 | 6 | 10,600 | 5 K to 10.6 K (+112.00 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.12 | 484 | 3,930 | 1,871,002 | 1.9 M to 1.9 M (-0.03 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.10 | 3,640 | 29,489 | 1,871,486 | 1.9 M to 1.9 M (-0.19 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.17 | 3,500 | 28,599 | 1,875,126 | 1.9 M to 1.9 M (-0.19 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.12 | 207 | 1,681 | 801,859 | 802.1 K to 801.9 K (-0.03 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 1,560 | 12,638 | 802,066 | 803.6 K to 802.1 K (-0.19 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.17 | 1,500 | 12,257 | 803,626 | 805.1 K to 803.6 K (-0.19 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.12 | 484 | 3,930 | 1,871,002 | 1.9 M to 1.9 M (-0.03 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 3,640 | 29,489 | 1,871,486 | 1.9 M to 1.9 M (-0.19 %) |
Feb 16 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.17 | 3,500 | 28,599 | 1,875,126 | 1.9 M to 1.9 M (-0.19 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 7,500 | 60,752 | 805,126 | 812.6 K to 805.1 K (-0.92 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.03 | 10,500 | 84,343 | 812,626 | 823.1 K to 812.6 K (-1.28 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.08 | 3,330 | 26,891 | 823,126 | 826.5 K to 823.1 K (-0.40 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.10 | 17,500 | 141,754 | 1,878,626 | 1.9 M to 1.9 M (-0.92 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.03 | 24,500 | 196,801 | 1,896,126 | 1.9 M to 1.9 M (-1.28 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 8.08 | 7,770 | 62,747 | 1,920,626 | 1.9 M to 1.9 M (-0.40 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.10 | 17,500 | 141,754 | 1,878,626 | 1.9 M to 1.9 M (-0.92 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.03 | 24,500 | 196,801 | 1,896,126 | 1.9 M to 1.9 M (-1.28 %) |
Feb 13 2007 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR GROWTH CAPITAL LTD | 10% Owner | Sell | S | 8.08 | 7,770 | 62,747 | 1,920,626 | 1.9 M to 1.9 M (-0.40 %) |
Nov 21 2006 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 6.42 | 21,666 | 139,096 | 21,666 | |
Nov 21 2006 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 6.42 | 19,934 | 127,976 | 19,934 | |
Nov 21 2006 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 2,000 | 2 | 2,000 | 0 to 2 K |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 7.98 | 300 | 2,394 | 26,500 | 26.2 K to 26.5 K (+1.15 %) |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | CLASSON ROLF A | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Oct 23 2006 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 6.08 | 16,000 | 97,280 | 16,000 | |
Jun 26 2006 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | P | 7.75 | 4,500,000 | 34,875,000 | 4,500,000 | |
Jun 26 2006 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | P | 7.75 | 4,500,000 | 34,875,000 | 4,500,000 | |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 543 | 3,059 | 585,055 | 584.5 K to 585.1 K (+0.09 %) |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 269 | 1,515 | 290,757 | 290.5 K to 290.8 K (+0.09 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 50,804 | 293,144 | 584,512 | 533.7 K to 584.5 K (+9.52 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 25,247 | 145,678 | 290,488 | 265.2 K to 290.5 K (+9.52 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 3,140 | 17,990 | 533,708 | 530.6 K to 533.7 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 1,560 | 8,938 | 265,241 | 263.7 K to 265.2 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 11,910 | 66,616 | 530,568 | 518.7 K to 530.6 K (+2.30 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 5,918 | 33,101 | 263,681 | 257.8 K to 263.7 K (+2.30 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 68,163 | 380,390 | 518,658 | 450.5 K to 518.7 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 33,877 | 189,054 | 257,763 | 223.9 K to 257.8 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 817 | 4,696 | 450,495 | 449.7 K to 450.5 K (+0.18 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 405 | 2,328 | 223,886 | 223.5 K to 223.9 K (+0.18 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 68,559 | 390,348 | 449,678 | 381.1 K to 449.7 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 34,073 | 193,998 | 223,481 | 189.4 K to 223.5 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 33,581 | 189,860 | 381,119 | 347.5 K to 381.1 K (+9.66 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 16,687 | 94,345 | 189,408 | 172.7 K to 189.4 K (+9.66 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 20,241 | 115,487 | 347,538 | 327.3 K to 347.5 K (+6.18 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 10,059 | 57,393 | 172,721 | 162.7 K to 172.7 K (+6.18 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 6,410 | 36,836 | 327,297 | 320.9 K to 327.3 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 3,185 | 18,303 | 162,662 | 159.5 K to 162.7 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 6,914 | 39,679 | 320,887 | 314 K to 320.9 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 3,436 | 19,719 | 159,477 | 156 K to 159.5 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 37,769 | 217,036 | 313,973 | 276.2 K to 314 K (+13.67 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 18,770 | 107,860 | 156,041 | 137.3 K to 156 K (+13.67 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 25,702 | 144,602 | 276,204 | 250.5 K to 276.2 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 12,773 | 71,862 | 137,271 | 124.5 K to 137.3 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 14,028 | 82,326 | 250,502 | 236.5 K to 250.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 6,972 | 40,917 | 124,498 | 117.5 K to 124.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 9,286 | 54,787 | 236,474 | 227.2 K to 236.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 4,614 | 27,223 | 117,526 | 112.9 K to 117.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 5,647 | 32,649 | 227,188 | 221.5 K to 227.2 K (+2.55 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 2,806 | 16,223 | 112,912 | 110.1 K to 112.9 K (+2.55 %) |
May 03 2006 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 5.75 | 20,000 | 115,000 | 20,000 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 6.77 | 39,900 | 270,123 | 39,900 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Grant | A | 0.00 | 5,600 | 6 | 12,721 | 7.1 K to 12.7 K (+78.64 %) |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 6.77 | 43,400 | 293,818 | 43,400 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 6,100 | 6 | 6,100 | 0 to 6.1 K |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | GRILLONE LISA R | Vice President, Cli ... | Option Exercise | A | 6.77 | 17,300 | 117,121 | 17,300 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | GRILLONE LISA R | Vice President, Cli ... | Grant | A | 0.00 | 3,500 | 4 | 3,500 | 0 to 3.5 K |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corporat ... | Option Exercise | A | 6.77 | 32,100 | 217,317 | 32,100 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corporat ... | Grant | A | 0.00 | 4,300 | 4 | 5,102 | 802 to 5.1 K (+536.16 %) |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.77 | 130,200 | 881,454 | 130,200 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 18,600 | 19 | 31,900 | 13.3 K to 31.9 K (+139.85 %) |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Option Exercise | A | 6.77 | 30,300 | 205,131 | 30,300 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Grant | A | 0.00 | 3,900 | 4 | 3,900 | 0 to 3.9 K |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 6.77 | 32,100 | 217,317 | 32,100 | |
Feb 21 2006 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 4,200 | 4 | 4,200 | 0 to 4.2 K |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | NELSON LIZA PAGE | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | CLASSON ROLF A | Director | Option Exercise | A | 10.17 | 32,500 | 330,525 | 32,500 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | CLASSON ROLF A | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 10.17 | 32,500 | 330,525 | 32,500 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Oct 14 2005 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 5.82 | 16,000 | 93,120 | 16,000 | |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.85 | 120 | 1,182 | 825,434 | 825.6 K to 825.4 K (-0.01 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.80 | 630 | 6,174 | 825,554 | 826.2 K to 825.6 K (-0.08 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.93 | 60 | 596 | 826,184 | 826.2 K to 826.2 K (-0.01 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.92 | 690 | 6,845 | 826,244 | 826.9 K to 826.2 K (-0.08 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.95 | 3,239 | 32,228 | 826,934 | 830.2 K to 826.9 K (-0.39 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.63 | 30 | 289 | 830,173 | 830.2 K to 830.2 K (0.00 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.60 | 2,970 | 28,512 | 830,203 | 833.2 K to 830.2 K (-0.36 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.70 | 1,261 | 12,232 | 833,173 | 834.4 K to 833.2 K (-0.15 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.85 | 280 | 2,758 | 1,928,396 | 1.9 M to 1.9 M (-0.01 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.80 | 1,470 | 14,406 | 1,928,676 | 1.9 M to 1.9 M (-0.08 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.93 | 140 | 1,390 | 1,930,146 | 1.9 M to 1.9 M (-0.01 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.92 | 1,610 | 15,971 | 1,930,286 | 1.9 M to 1.9 M (-0.08 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.95 | 7,558 | 75,202 | 1,931,896 | 1.9 M to 1.9 M (-0.39 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.63 | 70 | 674 | 1,939,454 | 1.9 M to 1.9 M (0.00 %) |
Jul 22 2005 | ISTA | ISTA PHARMACEUTICA ... | INVESTOR AB | 10% Owner | Sell | S | 9.60 | 6,930 | 66,528 | 1,939,524 | 1.9 M to 1.9 M (-0.36 %) |